| Title : Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-kappaB pathways - Su_2017_Naunyn.Schmiedebergs.Arch.Pharmacol_390_1189 |
| Author(s) : Su SH , Wu YF , Lin Q , Hai J |
| Ref : Naunyn Schmiedebergs Arch Pharmacol , 390 :1189 , 2017 |
| Abstract : Su_2017_Naunyn.Schmiedebergs.Arch.Pharmacol_390_1189 |
| ESTHER : Su_2017_Naunyn.Schmiedebergs.Arch.Pharmacol_390_1189 |
| PubMedSearch : Su_2017_Naunyn.Schmiedebergs.Arch.Pharmacol_390_1189 |
| PubMedID: 28825114 |
Su SH, Wu YF, Lin Q, Hai J (2017)
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-kappaB pathways
Naunyn Schmiedebergs Arch Pharmacol
390 :1189
Su SH, Wu YF, Lin Q, Hai J (2017)
Naunyn Schmiedebergs Arch Pharmacol
390 :1189